These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22923722)

  • 1. Interpatient variation in normal peripheral zone apparent diffusion coefficient: effect on the prediction of prostate cancer aggressiveness.
    Litjens GJ; Hambrock T; Hulsbergen-van de Kaa C; Barentsz JO; Huisman HJ
    Radiology; 2012 Oct; 265(1):260-6. PubMed ID: 22923722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
    Hambrock T; Somford DM; Huisman HJ; van Oort IM; Witjes JA; Hulsbergen-van de Kaa CA; Scheenen T; Barentsz JO
    Radiology; 2011 May; 259(2):453-61. PubMed ID: 21502392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer.
    Rosenkrantz AB; Sigmund EE; Johnson G; Babb JS; Mussi TC; Melamed J; Taneja SS; Lee VS; Jensen JH
    Radiology; 2012 Jul; 264(1):126-35. PubMed ID: 22550312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
    Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
    Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T.
    Nagel KN; Schouten MG; Hambrock T; Litjens GJ; Hoeks CM; ten Haken B; Barentsz JO; Fütterer JJ
    Radiology; 2013 Apr; 267(1):164-72. PubMed ID: 23329653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers.
    Langer DL; van der Kwast TH; Evans AJ; Sun L; Yaffe MJ; Trachtenberg J; Haider MA
    Radiology; 2008 Dec; 249(3):900-8. PubMed ID: 19011187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis.
    Tamada T; Sone T; Jo Y; Yamamoto A; Yamashita T; Egashira N; Imai S; Fukunaga M
    Radiology; 2008 Aug; 248(2):531-9. PubMed ID: 18539890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion tensor magnetic resonance imaging of prostate cancer.
    Manenti G; Carlani M; Mancino S; Colangelo V; Di Roma M; Squillaci E; Simonetti G
    Invest Radiol; 2007 Jun; 42(6):412-9. PubMed ID: 17507813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do apparent diffusion coefficient (ADC) values obtained using high b-values with a 3-T MRI correlate better than a transrectal ultrasound (TRUS)-guided biopsy with true Gleason scores obtained from radical prostatectomy specimens for patients with prostate cancer?
    Kitajima K; Takahashi S; Ueno Y; Miyake H; Fujisawa M; Kawakami F; Sugimura K
    Eur J Radiol; 2013 Aug; 82(8):1219-26. PubMed ID: 23518144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of diffusion-weighted-MRI in prostate cancer.
    Wibulpolprasert P; Phongkitkarun S; Chalermsanyakorn P
    J Med Assoc Thai; 2013 Aug; 96(8):967-75. PubMed ID: 23991605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm²) and standard high b-value (1000 s/mm²).
    Kitajima K; Takahashi S; Ueno Y; Yoshikawa T; Ohno Y; Obara M; Miyake H; Fujisawa M; Sugimura K
    J Magn Reson Imaging; 2012 Jul; 36(1):198-205. PubMed ID: 22371381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the normal-to-diseased apparent diffusion coefficient ratio as an indicator of prostate cancer aggressiveness.
    Lebovici A; Sfrangeu SA; Feier D; Caraiani C; Lucan C; Suciu M; Elec F; Iacob G; Buruian M
    BMC Med Imaging; 2014 May; 14():15. PubMed ID: 24885552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features.
    Langer DL; van der Kwast TH; Evans AJ; Plotkin A; Trachtenberg J; Wilson BC; Haider MA
    Radiology; 2010 May; 255(2):485-94. PubMed ID: 20413761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut-off value to predict malignancy of the peripheral zone.
    Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Dwivedi SN; Hemal AK; Gupta NP
    NMR Biomed; 2007 Aug; 20(5):505-11. PubMed ID: 17167820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.
    Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B
    J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
    Somford DM; Hambrock T; Hulsbergen-van de Kaa CA; Fütterer JJ; van Oort IM; van Basten JP; Karthaus HF; Witjes JA; Barentsz JO
    Invest Radiol; 2012 Mar; 47(3):153-8. PubMed ID: 22293513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region.
    Kim JH; Kim JK; Park BW; Kim N; Cho KS
    J Magn Reson Imaging; 2008 Nov; 28(5):1173-9. PubMed ID: 18837000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue.
    Hosseinzadeh K; Schwarz SD
    J Magn Reson Imaging; 2004 Oct; 20(4):654-61. PubMed ID: 15390142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.
    Gupta RT; Kauffman CR; Garcia-Reyes K; Palmeri ML; Madden JF; Polascik TJ; Rosenkrantz AB
    AJR Am J Roentgenol; 2015 Aug; 205(2):331-6. PubMed ID: 26204283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.